Pharmacovigilance study of anti-infective-related acute kidney injury using the Japanese adverse drug event report database

被引：0
|
作者：
Satoshi Nakao
Shiori Hasegawa
Ryogo Umetsu
Kazuyo Shimada
Ririka Mukai
Mizuki Tanaka
Kiyoka Matsumoto
Yu Yoshida
Misaki Inoue
Riko Satake
Yuri Nishibata
Jun Liao
Mitsuhiro Nakamura
机构：
[1] Gifu Pharmaceutical University; Gifu,Laboratory of Drug Informatics
[2] Kyushu University Hospital,Present Address: Department of Pharmacy
[3] Kobe City Medical Center General Hospital,Division of Pharmacy
[4] Present Address: Micron Inc,Department of Pharmaceutical Informatics and Biological Statistics, School of Science
[5] Present Address: Division of Pharmacy,undefined
[6] Japanese Red Cross Wakayama Medical Center,undefined
[7] China Pharmaceutical University,undefined
来源：
BMC Pharmacology and Toxicology | / 22卷
关键词：
Acute kidney injury; Anti-infective; Japanese adverse drug event report database; Propensity score; JADER; Polypharmacy;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [21] Thromboembolic adverse event study of combined estrogen-progestin preparations using Japanese Adverse Drug Event Report database
    Hasegawa, Shiori
    Matsui, Toshinobu
    Hane, Yuuki
    Abe, Junko
    Hatahira, Haruna
    Motooka, Yumi
    Sasaoka, Sayaka
    Fukuda, Akiho
    Naganuma, Misa
    Hirade, Kouseki
    Takahashi, Yukiko
    Kinosada, Yasutomi
    Nakamura, Mitsuhiro
    PLOS ONE, 2017, 12 (07):
  • [22] Influence of Japanese Regulatory Action on Denosumab-Related Hypocalcemia Using Japanese Adverse Drug Event Report Database
    Takeyama, Mayu
    Sai, Kimie
    Imatoh, Takuya
    Segawa, Katsunori
    Hirasawa, Noriyasu
    Saito, Yoshiro
    BIOLOGICAL & PHARMACEUTICAL BULLETIN, 2017, 40 (09) : 1447 - 1453
  • [23] A Pharmacovigilance Approach for Post-Marketing in Japan Using the Japanese Adverse Drug Event Report (JADER) Database and Association Analysis
    Fujiwara, Masakazu
    Kawasaki, Yohei
    Yamada, Hiroshi
    PLOS ONE, 2016, 11 (04):
  • [24] Analysis of adverse drug events in patients with bipolar disorders using the Japanese Adverse Drug Event Report database
    Uwai, Y.
    Nabekura, I
    PHARMAZIE, 2022, 77 (7-9): : 255 - 261
  • [25] Time until onset of acute kidney injury by combination therapy with "Triple Whammy" drugs obtained from Japanese Adverse Drug Event Report database
    Kunitsu, Yuki
    Hira, Daiki
    Morikochi, Aya
    Ueda, Tomohiro
    Isono, Tetsuichiro
    Morita, Shin-ya
    Terada, Tomohiro
    PLOS ONE, 2022, 17 (02):
  • [26] Adverse event profiles of microscopic colitis in the Japanese Adverse Drug Event Report (JADER) database
    Kaito Yamashiro
    Mika Jouta
    Kouichi Hosomi
    Satoshi Yokoyama
    Yuu Ozaki
    Atsushi Hirata
    Fumihiko Ogata
    Takehiro Nakamura
    Shigeharu Tanei
    Naohito Kawasaki
    Scientific Reports, 12
  • [27] Adverse event profiles of microscopic colitis in the Japanese Adverse Drug Event Report (JADER) database
    Yamashiro, Kaito
    Jouta, Mika
    Hosomi, Kouichi
    Yokoyama, Satoshi
    Ozaki, Yuu
    Hirata, Atsushi
    Ogata, Fumihiko
    Nakamura, Takehiro
    Tanei, Shigeharu
    Kawasaki, Naohito
    SCIENTIFIC REPORTS, 2022, 12 (01)
  • [28] Progressive multifocal leukoencephalopathy analyzed using the Japanese Adverse Drug Event Report database
    Sakurai, Shuji
    Maezawa, Mika
    Nakao, Satoshi
    Hirofuji, Sakiko
    Miyasaka, Koumi
    Yamashita, Moe
    Matsui, Kensuke
    Nishida, Shohei
    Kobayashi, Ryo
    Iguchi, Kazuhiro
    Hayashi, Yuichi
    Suzuki, Akio
    Nakamura, Mitsuhiro
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2023, 455
  • [29] Comparison of Serious Adverse Event Profiles Among Antirheumatic Agents Using Japanese Adverse Drug Event Report Database
    Yomei Matsuoka
    Mamoru Narukawa
    Therapeutic Innovation & Regulatory Science, 2018, 52 : 339 - 347
  • [30] Comparison of Serious Adverse Event Profiles Among Antirheumatic Agents Using Japanese Adverse Drug Event Report Database
    Matsuoka, Yomei
    Narukawa, Mamoru
    THERAPEUTIC INNOVATION & REGULATORY SCIENCE, 2018, 52 (03) : 339 - 347
12345